Skip to main content
. 2011 Jun 20;9:94. doi: 10.1186/1479-5876-9-94

Table 6.

Correspondence between in vitro activity and clinical efficacy in individual tumors

In vitro results Clinical results
Primary Carboplatin/taxol
S/S S
R/S S
R/R R
R/R R
R/R R
R/R R
Carboplatin
R R
Recurrent Carboplatin/taxol
S/S S
R/S R
S/S S
S/R R
R/R R
R/R R
R/R R
R/R R
R/R R
R/R R
R/R R
Cisplatin/adriamycin
R/R R
S/S S
S/S S
S/S S
R/R R
R/R R
Carboplatin
R R
R R
Carboplatin/gemcitabine
R/R R
R/R R
Carboplatin/taxol/gemcitabine
R/R/R R
R/R/R R

S, sensitive; R, resistant